Health
Antibodies from COVID-19 infection protect patients for six months – Drug Target Review
A study in healthcare workers has shown that antibodies from COVID-19 infection protect individuals for at least six months.
Posted: 24 November 2020 | Victoria Rees (Drug Target Review) | No comments yet
A study in healthcare workers has shown that antibodies from COVID-19 infection protect individuals from reinfection for at least six months.
A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again for at least six months following their first infection. The study was conducted as part of a collaboration between the University of Oxford and Oxford University…
-
General24 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News9 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News23 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace
-
Noosa News23 hours agoBIGSOUND Is Back For 2025 With Over 130 Emerging Artists